Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

238
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
238
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

182
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
182
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Fractional Exhaled Nitric Oxide With Pulmonary Health and All-Cause Mortality in a Population Without Airflow Limitation.

Chronic obstructive pulmonary diseases (Miami, Fla.)·2026
Same author

Quantitative CT-Derived extrapulmonary body composition and the risk of acute exacerbations in COPD: A prospective cohort study.

Respiratory medicine·2026
Same author

COPD Patients with a High Exacerbation Risk: Baseline Data Analysis of a National Chinese Prospective Multi-Center Study of Quality Improvement Project.

International journal of chronic obstructive pulmonary disease·2026
Same author

Response.

Chest·2026
Same author

Correlation between left atrium fractal dimension and cardiac function in patients with atrial fibrillation.

The British journal of radiology·2026
Same author

Ultrafine Nanoporous Ordered High-Entropy Intermetallics with Isolated Multisites toward Electrocatalytic Aldehyde Hydrogenation.

Journal of the American Chemical Society·2026

Related Experiment Video

Updated: Jun 9, 2025

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

13.2K

Clinical and Prognostic Differences in Mild to Moderate COPD With and Without Emphysema.

Huajing Yang1, Yuqiong Yang2, Fengyan Wang2

  • 1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China; Guangzhou National Lab, Guangzhou, Guangdong, China.

Chest
|October 25, 2024
PubMed
Summary

Mild-to-moderate COPD with emphysema (EC) shows worse quality of life and more exacerbations than without emphysema (NEC). However, lung function decline was similar, and emphysema progression was slower in the EC group.

Keywords:
COPDemphysemaepidemiologymild to moderate

More Related Videos

Lung Fixation under Constant Pressure for Evaluation of Emphysema in Mice
05:48

Lung Fixation under Constant Pressure for Evaluation of Emphysema in Mice

Published on: September 26, 2019

8.9K
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

604

Related Experiment Videos

Last Updated: Jun 9, 2025

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
10:37

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

13.2K
Lung Fixation under Constant Pressure for Evaluation of Emphysema in Mice
05:48

Lung Fixation under Constant Pressure for Evaluation of Emphysema in Mice

Published on: September 26, 2019

8.9K
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
04:03

Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD

Published on: September 27, 2024

604

Area of Science:

  • Pulmonary Medicine
  • Radiology
  • Clinical Research

Background:

  • Clinical and prognostic characteristics of mild-to-moderate COPD with and without emphysema require further investigation.
  • Distinguishing between COPD subtypes based on emphysema presence is crucial for understanding disease trajectory.

Purpose of the Study:

  • To determine if clinical and prognostic characteristics differ between mild-to-moderate COPD patients with and without emphysema.
  • To compare lung function decline, quality of life, and exacerbation rates between these two COPD groups.

Main Methods:

  • Analysis of clinical data from 989 mild-to-moderate COPD participants in the SPIROMICS study.
  • Categorization into emphysema (EC) and non-emphysema (NEC) groups based on CT scan analysis.
  • Utilized linear mixed-effects models and zero-inflated negative binomial regressions to assess differences.

Main Results:

  • 43.3% of participants had emphysema (EC group).
  • Annual FEV1 decline was similar between EC (-56.1 mL/y) and NEC (-46.9 mL/y) groups.
  • The EC group experienced worse quality of life and a higher rate of acute respiratory exacerbations (1.42 rate ratio).

Conclusions:

  • Mild-to-moderate COPD with emphysema is associated with poorer quality of life and increased exacerbations, despite similar lung function decline.
  • The non-emphysema COPD subtype demonstrated faster emphysema progression.
  • These findings highlight distinct clinical trajectories for COPD subtypes.